Sort
23,748 grants matching “melanoma”
Role of PI3Kgamma in Tumor Progression and Metastasis
$509,078Judith A. Varner · University Of California, San Diego · R01 · FY2024 · CA
3D Models of Immunotherapy
$509,042David J Mooney · Harvard University · U01 · FY2021 · CA
Descriptive Studies and Record Linkage
$509,014Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$508,916Chad A. Mirkin · Northwestern University · R01 · FY2023 · CA
Developing Selective EphA2 Inhibitors for the treatment of Cancer
$508,812Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2014 · CA
UCLA Clinical Scientist Training in Cancer Gene Medicine
$508,680University Of California Los Angeles · K12 · FY2005 · CA
UCLA Clinical Scientist Training in Cancer Gene Medicine
$508,680University Of California Los Angeles · K12 · FY2004 · CA
UCLA Clinical Scientist Training in Cancer Gene Medicine
$508,680James S. Economou · University Of California Los Angeles · K12 · FY2006 · CA
UCLA Clinical Scientist Training in Cancer Gene Medicine
$508,680James S. Economou · University Of California Los Angeles · K12 · FY2007 · CA
HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers
$508,654Douglas F Nixon · George Washington University · R01 · FY2017 · CA
EPIGENETIC REGULATION OF THE MELANOMA MICROENVIRONMENT. NEW AWARD.
$508,497Icahn School Of Medicine At Mount Sinai · · FY2020 · Department of the Army
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves
$508,478Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Confocal line-scanning versus point-scanning for imaging human skin in vivo
$508,462Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2007 · EB
Functional analysis of a novelintegrin-dependent metastasis pathway in melanoma
$508,408Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2022 · CA
Glycosylation Mutants of Mice and Animal Cells
$508,261Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2008 · CA
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$508,105Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$508,083Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING
$507,926Prabhas V Moghe · Rutgers, The State Univ Of N.J. · R01 · FY2017 · EB
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$507,690Arthur Hurwitz · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma
$507,620Eva Hernando · New York University School Of Medicine · R01 · FY2022 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$507,564Thomas G Graeber · University Of California Los Angeles · P01 · FY2022 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$507,564Thomas G Graeber · University Of California Los Angeles · P01 · FY2023 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$507,564Roger S Lo · University Of California Los Angeles · P01 · FY2022 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$507,563Roger S Lo · University Of California Los Angeles · P01 · FY2023 · CA
Project 3: Modeling and overcoming resistance to melanoma immunotherapy
$507,562Antoni Ribas · University Of California Los Angeles · P01 · FY2022 · CA